MOLECULAR PARTNERS ADS/1 (6ML0) — Cash Flow Reinvestment Rate
MOLECULAR PARTNERS ADS/1 (6ML0) has a Cash Flow Reinvestment Rate of 0.86x as of December 2022, reinvesting €101.61 Million (capex €1.42 Million plus investments €-100.20 Million) from operating cash flow of €118.57 Million. Check earnings quality score of MOLECULAR PARTNERS ADS/1 to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
MOLECULAR PARTNERS ADS/1 Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for MOLECULAR PARTNERS ADS/1 across 1 annual periods. Explore MOLECULAR PARTNERS ADS/1 (6ML0) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for MOLECULAR PARTNERS ADS/1 (2022–2022)
Year-by-year capital reinvestment analysis for MOLECULAR PARTNERS ADS/1. For live market cap and broader valuation context, see MOLECULAR PARTNERS ADS/1 (6ML0) total market value.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.86x | €101.61 Million | €118.57 Million | €1.42 Million | — |